Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?
Rolleman
Edgar J
EJ
de Jong
Marion
M
Valkema
Roelf
R
Kwekkeboom
Dik
D
Kam
Boen
B
Krenning
Eric P
EP
D000596:Amino Acids / Q000627:therapeutic use*; D000818:Animals; D005780:Gelatin / Q000627:therapeutic use*; D006801:Humans; D007205:Indium Radioisotopes; D007668:Kidney / Q000187:drug effects* / Q000528:radiation effects; D007674:Kidney Diseases / Q000517:prevention & control; D051379:Mice; D015282:Octreotide / Q000009:adverse effects / Q000031:analogs & derivatives*; D004369:Pentetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D011832:Radiation Injuries / Q000517:prevention & control*; D011833:Radiation Injuries, Experimental / Q000517:prevention & control; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D019275:Radiopharmaceuticals / Q000009:adverse effects*; D051381:Rats; D013386:Succinates / Q000627:therapeutic use*
C497824:111In-octreotide, DTPA(0)-; D000596:Amino Acids; D007205:Indium Radioisotopes; D011837:Radiation-Protective Agents; D019275:Radiopharmaceuticals; D013386:Succinates; C060085:succinylated gelatin; D004369:Pentetic Acid; D005780:Gelatin; D015282:Octreotide